WO2001036457A3 - Chlamydia antigens and corresponding dna fragments and uses thereof - Google Patents

Chlamydia antigens and corresponding dna fragments and uses thereof Download PDF

Info

Publication number
WO2001036457A3
WO2001036457A3 PCT/CA2000/001346 CA0001346W WO0136457A3 WO 2001036457 A3 WO2001036457 A3 WO 2001036457A3 CA 0001346 W CA0001346 W CA 0001346W WO 0136457 A3 WO0136457 A3 WO 0136457A3
Authority
WO
WIPO (PCT)
Prior art keywords
dna fragments
corresponding dna
chlamydia
chlamydia antigens
strain
Prior art date
Application number
PCT/CA2000/001346
Other languages
French (fr)
Other versions
WO2001036457A2 (en
Inventor
Andrew D Murdin
Raymond P Oomen
Joe Wang
Pamela Dunn
Original Assignee
Aventis Pasteur
Andrew D Murdin
Raymond P Oomen
Joe Wang
Pamela Dunn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur, Andrew D Murdin, Raymond P Oomen, Joe Wang, Pamela Dunn filed Critical Aventis Pasteur
Priority to AU13757/01A priority Critical patent/AU1375701A/en
Publication of WO2001036457A2 publication Critical patent/WO2001036457A2/en
Publication of WO2001036457A3 publication Critical patent/WO2001036457A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Abstract

The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector containing a nucleotide sequence encoding an amino acid transporter of a strain of Chlamydia pneumoniae and a promoter to effect expression of the amino acid transporter in the host. Modifications are possible within the scope of this invention.
PCT/CA2000/001346 1999-11-15 2000-11-10 Chlamydia antigens and corresponding dna fragments and uses thereof WO2001036457A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU13757/01A AU1375701A (en) 1999-11-15 2000-11-10 Chlamydia antigens and corresponding DNA fragments and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16561599P 1999-11-15 1999-11-15
US60/165,615 1999-11-15

Publications (2)

Publication Number Publication Date
WO2001036457A2 WO2001036457A2 (en) 2001-05-25
WO2001036457A3 true WO2001036457A3 (en) 2001-11-01

Family

ID=22599666

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2000/001346 WO2001036457A2 (en) 1999-11-15 2000-11-10 Chlamydia antigens and corresponding dna fragments and uses thereof

Country Status (2)

Country Link
AU (1) AU1375701A (en)
WO (1) WO2001036457A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999027105A2 (en) * 1997-11-21 1999-06-03 Genset Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999027105A2 (en) * 1997-11-21 1999-06-03 Genset Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL EBI; 1 May 1999 (1999-05-01), "AMINO ACID TRANSPORTER from Chlamydia pneumoniae", XP002166388 *
DATABASE EMBL EBI; 15 March 1999 (1999-03-15), "Chlamydia pneumoniae section 29 of 103 of the complete genome", XP002166389 *

Also Published As

Publication number Publication date
AU1375701A (en) 2001-05-30
WO2001036457A2 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
WO2001046224A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2000066739A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2003070760A3 (en) Anti-amyloid beta antibodies and their use
BR9712971A (en) Method for producing a vaccine to protect a host against disease caused by a chlamydia chain and immunological composition
WO2005070958A3 (en) Lawsonia intracellularis subunit vaccines
EP1220925B8 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001046225A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
ATE348892T1 (en) CHLAMYDIA ANTIGENS, CORRESPONDING DNA FRAGMENTS AND THEIR USES
WO2001075111A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001075113A3 (en) Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof
WO2003093316A3 (en) Immunoglobulin-domain containing cell surface recognition molecules
WO2001074863A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001075112A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001075114A3 (en) Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof
EP2172214A3 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
WO2000006742A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO1999051745A3 (en) Dna immunization against chlamydia infection
WO2003012099A1 (en) Chondroitin synthase
WO2005026200A3 (en) Lawsonia intracellularis subunit vaccine
WO2000026239A3 (en) $i(chlamydia) antigens and corresponding dna fragments and uses thereof
WO2001046226A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
MXPA01004353A (en) Chlamydia.
WO2000011183A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2002010336A3 (en) Mutacin i biosynthesis genes and proteins
WO2000006743A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase